<p>Tympanic paragangliomas (glomus tympanicum tumors) are rare benign vascular neoplasms of middle ear paraganglionic tissue. This ambispective single-institutional study evaluates the strategic approaches adopted in the management of tympanic paragangliomas, analyzing the effectiveness of a newly implemented treatment algorithm with respect to surgical outcomes and recurrence rates. This study analyzed 28 patients with tympanic paragangliomas managed by a proposed algorithm between 2020 and 2024. Surgical approaches varied by tumor stage, from transcanal and endaural to mastoidectomy and infratemporal techniques. Key outcomes assessed included hearing preservation, recurrence, intraoperative complications, and long-term functional results. Of the 28 patients, 57.1% were female, and the median tumor size was 2.0&#xa0;cm. The most common presenting symptoms were hearing loss (89.2%) and pulsatile tinnitus (85.7%). Surgical approaches varied based on tumor stage, with a majority undergoing either endaural or mastoidectomy procedures. Ossicular chain erosion was observed in 70.83% of cases. Postoperatively, hearing outcomes showed significant improvement or stabilization, with air-bone gap closure from 13.5 dB to 7.6 dB. Recurrence was observed in only one patient during the 18-month follow-up. No permanent facial nerve palsy occurred. The strategic management of glomus tympanicum tumors using a tailored approach based on tumor staging yields favourable long-term outcomes. Hearing preservation and low recurrence rates underscore the effectiveness of the newly implemented surgical algorithm, offering a refined approach to managing these complex middle ear tumors.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Strategic Approaches in the Management of Tympanic Paragangliomas: A Single-Institutional Experience

  • Nidhin Das K,
  • Mohit Sinha,
  • Ravi Sankar Manogaran,
  • Kuntal Kanti Das,
  • Nazrin Hameed,
  • Mohd Aqib,
  • Kalyan Chidambaram,
  • Amit Keshri

摘要

Tympanic paragangliomas (glomus tympanicum tumors) are rare benign vascular neoplasms of middle ear paraganglionic tissue. This ambispective single-institutional study evaluates the strategic approaches adopted in the management of tympanic paragangliomas, analyzing the effectiveness of a newly implemented treatment algorithm with respect to surgical outcomes and recurrence rates. This study analyzed 28 patients with tympanic paragangliomas managed by a proposed algorithm between 2020 and 2024. Surgical approaches varied by tumor stage, from transcanal and endaural to mastoidectomy and infratemporal techniques. Key outcomes assessed included hearing preservation, recurrence, intraoperative complications, and long-term functional results. Of the 28 patients, 57.1% were female, and the median tumor size was 2.0 cm. The most common presenting symptoms were hearing loss (89.2%) and pulsatile tinnitus (85.7%). Surgical approaches varied based on tumor stage, with a majority undergoing either endaural or mastoidectomy procedures. Ossicular chain erosion was observed in 70.83% of cases. Postoperatively, hearing outcomes showed significant improvement or stabilization, with air-bone gap closure from 13.5 dB to 7.6 dB. Recurrence was observed in only one patient during the 18-month follow-up. No permanent facial nerve palsy occurred. The strategic management of glomus tympanicum tumors using a tailored approach based on tumor staging yields favourable long-term outcomes. Hearing preservation and low recurrence rates underscore the effectiveness of the newly implemented surgical algorithm, offering a refined approach to managing these complex middle ear tumors.